Lessons learned from Bowel Screening Pilot Clinical Director’s perspective Mike Hulme-Moir.

Slides:



Advertisements
Similar presentations
Ilkeston Hospital DTC – Extending the Role of Community Hospitals Paula Clark - Erewash PCT.
Advertisements

Allied Health Professionals with Special Interest. AHPwSI
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
A COMPARISON of LAPAROSCOPICALLY ASSISTED and OPEN COLECTOMY for COLON CANCER The Clinical Outcomes of Surgical Therapy Study Group (Cost Study) NEJM,
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Laparoscopic Colon Surgery
CHARACTERISTICS OF PATIENTS WITH COLORECTAL CANCER IN NORTHWESTERN GREECE Dimitrios Christodoulou, Ioannis Mitselos, Chrisanthi Tzika, Epameinondas V.
Surgical Management of Malignant Colonic Obstruction
Emergency Laparoscopic Surgery
The diabetic vascular foot (a 20 week snap shot review) Martin Arissol Vascular podiatrist.
Maureen Sayer Health Improvement Practitioner Cheshire and Merseyside Bowel Cancer Screening Programme.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Mr D Light ST5 Mr S Subramonia Consultant Laparoscopic Colorectal Surgeon Consultant Laparoscopic Colorectal Surgeon Mr A Krishna Consultant Laparoscopic.
Treatment of Acute Lower Gastrointestinal Bleeding Experience of a Specialized Management Team Eric J. Dozois, MD Division of Colon & Rectal Surgery Mayo.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
A CMH Community DocTalk with Robert Wayne, MD, FACS.
Colonoscopy; Surveillance Indications
Survivorship Update January 2015 The Royal Wolverhampton NHS Trust James Owen Senior Cancer Services Manager.
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
PERISTOMAL HERNIA: THE CASE FOR EXTRAPERITONEAL COLOSTOMY Garnet Blatchford, M.D.
Northern Region Colorectal Cancer Audit (NORCCAG) Colorectal NSSG – Audit meeting 1 st April 2006 – 31 st July 2010 Dorothy Simms – Audit Co-ordinator.
Colorectal cancer Khayal AlKhayal MD,FRCSC Assistant professor of Surgery Consultant Colorectal surgeon 9/11/2015Shwartz.
Should colonoscopy be performed one year out from colorectal cancer resection? Alexandra Kent, Philip Thompson, Prof Alan Horgan, Mr Paul Hainsworth Newcastle.
London cancer services: Implementing the model of care London Borough of Bromley Health Scrutiny Sub-Committee meeting Tuesday, November 15, 2011.
Colorectal Screening NZ Bowel Screening Pilot. WHO Screening criteria  Impt Health condition  Identifiable Latent or early stage  Understand natural.
The Bowel Screening Pilot: a pathologist’s perspective Dr Nicole Kramer Anatomic pathologist LabPlus, Auckland City Hospital.
T4 Colon Cancer and Laparoscopic Approach Gustavo Plasencia MD FACS, FASCRS Clinical Professor of Surgery Gustavo Plasencia MD FACS, FASCRS Clinical Professor.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
Fecal calprotectin DR Amin Eftekhari.
SETTING UP THE SERVICE BY LYNN TOBIN. HOW DID WE GET HERE? ABUNDENCE OF EVIDENCE PROVIDING JUSTIFICATION FOR BOWEL CANCER SCREENING.
PREPARED BY National Bowel Screening Programme Meeting 19 August 2015.
NSSG OG AUDIT DAY 2012 South Tees Hospitals Foundation Trust Sam Dresner, Consultant Surgeon Helen Wescott, OG Cancer CNS.
Operations for Suspected Appendicitis How good are we? Kim Bailey CT2.
PREPARED BY Colorectal Cancer Programme Screening for Colorectal Cancer A/P Susan Parry, Gastroenterologist, CD MOH Bowel Cancer Programme.
A National Bowel Screening Programme Anticipated Colonoscopy Volumes Susan Parry Gastroenterologist, Clinical Director, MOH Bowel Cancer Programme Emmanuel.
Perspectives from the Waitemata Bowel Screening Pilot team -The Endoscopic view Paul Frankish Lead Endoscopist.
NSSG OG AUDIT DAY 2013 South Tees Hospitals Foundation Trust Sam Dresner, Consultant Surgeon Helen Wescott, OG Cancer CNS.
Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.
General Surgery DnC Sundeep Guliani. HS 53 yo male screening colonoscopy -> endoscopically unresectable 2.5 cm ascending colon polyp PMH/PSH: Unremarkable.
A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &
Crohn’s Colitis SR Brown Colorectal Surgeon Sheffield Teaching Hospitals.
MSK pathway What is the MSK service? This is a multi- professional screening, assessment and treatment service. It has been set up by the RSCH together.
Medway Care Home Team Dr Sanjay Suman – Consultant Geriatrician - Medway Foundation Trust Prina Sahdev – Care Homes Pharmacist - Medway CCG.
Cancer Clinical Nurse Specialist experience of clinical pathways. Cheryl MacDonald. Clinical Nurse Specialist – Lead: Breast Care Maria Stapleton. Clinical.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Measuring outcomes in colorectal surgery: the nurse’s role
Patient Held Stoma Diary
Oesophagectomy Enhanced recovery Pathway
Mechanical bowel preparation with oral antibiotics reduces surgical site infection and anastomotic leak rate following elective colorectal resections.
The State of Thoracic Surgery 2014
Developments in colorectal surgery
Surgeon intuition is inferior to a simple web-based risk calculator for predicting anastomotic leak. Tarik Sammour, Mark Lewis, Michelle L Thomas, Matt.
Emergency laparoscopic stoma for obstructing colorectal cancer
Laparoscopic vs Open Colonic Surgery: Long Term Survival
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Background 8-29 % of patients with colon cancer present with partial or total obstruction (1) Emergency surgery is associated with up to 25% mortality.
Lean service redesign in GI: with productive outpatients
NHS ADULT SCREENING PROGRAMMES
Bowel Screening in Wales
What to look out for and why?
ESOPS East Sussex Outpatient Services Ltd an independent provider within the NHS family January 2018 ©ESOPS 2008.
Pathway for patients with suspected colorectal cancer
Worcestershire Colorectal Cancer 2ww Pathway
Medway Care Home Team Dr Sanjay Suman – Consultant Geriatrician - Medway Foundation Trust Prina Sahdev – Care Homes Pharmacist - Medway CCG.
Ambulatory Safety Nets: Creating High-Reliability Solutions to Prevent Missed and Delayed Diagnoses Sonali Desai, MD, MPH April 3, 2019.
Colorectal 2 week wait pathways and “Getting FIT”
Colorectal Disease: Conditions and Treatment Updates
Presentation transcript:

Lessons learned from Bowel Screening Pilot Clinical Director’s perspective Mike Hulme-Moir

Clinical Director Background colorectal surgery Broad role encompassing: -Public relations/Front person/Communication (Team, Patients, Management, MOH, GPs, Cancer, clinicians, Media/Public, Lab) -Quality overarching principle -Clinical work endoscopy, histopathology, -Problem solving (team based) -Expect the unexpected

Build a good team Too much for one person to do sans support Management, nursing, endoscopy, surgical, quality, GP, pathology/Lab

GPs Valuable/Vital/Essential component of our program Need total buy-in from them Education/Liaison Education takes time……lots of time, mainly after hours Need to be available preferably on the phone to talk over issues

Endoscopy Governance/Quality Currently no permanent national structure to ensure and oversee quality within a national bowel screening program NEQuip has provided excellent service to date but its future structure/funding is uncertain NOW is the time to sort out a national endoscopy governance structure with the following aims: To set acceptable standards for competence in endoscopic procedures To quality assure endoscopy units To quality assure endoscopy training To quality assure endoscopy services Governance body should service all endoscopy not just screening

Histopathology There are thousands of results in first 3 years Consistency is vital esp surveillance recommendations Less is best but one is too few!!! Nurse led histology is an answer Fellow consultants like to own their own histology Formatted letters with personalised service as needed

Cancer management Histopathology Referral processes MDM Workforce issues Initial hump and then ongoing referrals

Referral processes Robust..don’t lose pts Standardised Efficient ie get bloods and radiology done up front (2 week agreement with radiology) Colon ct, blds, info pack,mdm referral Rectal ct, mri, blds, info pack, mdm referral Provide information to patients

MDM Need one!!! Quality standard Many are easy Many are not! Rectal cancer Malignant polyps Advanced disease

Bowel Screening findings ( ) 5818 public colonoscopies in 5716 patients, 516 private colonoscopies 271 cancers in 261 patients 231 cancers/224 patients treated in public 40 cancers/37 patients treated in private 148 males, 113 females 10 public non-adenocarcinoma cancers/lesions (scc,carcinoid etc) 3 ot (r-hemi x2 and eua bx), 2 chemo/rad, 1 chemo 27 pub pts required OT for benign disease (polyps DD etc) -15 r hemicolectomy -3 ant resection +/- ileostomy -1 transverse colectomy -1 subtotal colectomy -7 TEMs or trans anal procedures 1 Private non adenoca cancers/lesions -1 chemo/rad 4 priv pts required OT for benign disease -3 r hemicolecotomy -1 high ant resection

Total BSP cancers n = 271

BSP vs Symptomatic cancer workload (2014 n= 359 of 450 P1 referrals, not including 15 non adenocarcinomas)

BSP cancer impact Surgical work load - New Pt clinic time average one hour per new cancer - (includes FSA, nurse specialist, stoma and ERAS) - Operating time on average one half day list per cancer - 11/181 pts leaked (6%) - 9 needed extra half day lists to fix and rejoin - Follow-up clinics several over 5 years - Stoma closure average of 15 per year (7.5 lists) - 2/10 FTE for BSP CD Endoscopy work load - Extra lists for complicated pts or polyps mostly under ga - Surveillance - Cancer followup scope at 3 years/5yearly thereafter

BSP cancer impact Laboratory work load (doesn’t include polyp work) - 3 hours per cancer (on average) 1 hr technician time 1.75 hrs pathologist time.25 hrs clerical time - Lab tests for inpatients Radiology - Every patient needs a staging CT - All rectal cancers need an MRI as well - Almost all major complications needed CTs, also one ivc filter for PE Ancillary services - CNS see each patient - Ethnic support services, cancer tracking - Stoma therapists (46 stomas, 2 permanent and 44 temporary) Bed space 6 day median bed stay for elective colorectal cancer surgery

Colonoscopic/Surgical complications 68 readmits from colonoscopy 6 laparotomies for bleeding(4), perforation (2) 11 leaks 9 reoperation and 2 non operative

Workload data WDHB population 575,000 Assume one surgeon 2 x 4 hour lists per week for 46 weeks per year (92 lists per year) plus 1 x 4 hour clinic, 1 x 4 hour endo list We need 0.5 FTE surgeon per year to cope with the new bsp work load but in addition there is extra work closing stomas (7.5 lists per year (2 per list). Real FTE is probably closer to.6 Acute surgery per year as a result of BSP ie 3 leaks, 2 laparotomies for bleeding/perf per year Approx.1 FTE surgery for each 100,000 population screened